VitalSigns
Return to the Blog Homepage

Category Archives: Healthcare

June 14, 2017

0 Comments

Written by

Categories: Agency Culture, Communications, Healthcare, Workplace Wellness

Happiness and Productivity: A Package Deal

How happy are you? This question has motivated countless shifts in workplace philosophy and policies in recent years, and for good reason; research shows that happiness can result in a productivity increase of about 12 percent. But what can companies...

June 12, 2017

0 Comments

Written by

Categories: Global Healthcare, Healthcare, The Week That Was

The Week That Was: Crises in Communications

They say the news never sleeps, and this week, we believe it. Comey-fever gripped the nation, answering some of the nation’s burning questions while raising a few others (tapes, anyone?)… Elsewhere on Capitol Hill, Senate Republicans started working to get...

June 12, 2017

0 Comments

Written by

Categories: Food and Beverage, Healthcare, Patient Communications

Med-Sci Matters by Dr. Dave

Pricey ads? At AMA’s meeting now underway, members will vote on a resolution to persuade FDA, FCC and FTC that retail prices of drugs must be included in all direct-to-consumer (DTC) ads.  The proposal can be found here.  Among the...

May 31, 2017

0 Comments

Written by

Categories: Agency Culture, Communications, Healthcare

Can Culture Define an Agency?

Organizational culture and its impact on company performance and productivity has long been debated – with many polarizing opinions. Some believe that you need to have a strong culture in place first in order to achieve maximum performance levels.  Others...

May 26, 2017

0 Comments

Written by

Categories: Global Healthcare, Health, Healthcare

Med-Sci Matters by Dr. Dave

Genetic markers: Do you approve? For the first time ever, the FDA has approved a therapy based on a tumor’s genetically-defined biomarker rather than the tumor’s type or location in the body. This new approach to drug evaluation is thought...

Dr. Dave’s Med-Sci Matters

Gene therapy success! For the first time, gene therapy has successfully treated a common genetic disorder:  sickle cell disease (SCD), which affects 100,000 people in the United States and millions globally. People with SCD have abnormal hemoglobin due to a...

April 3, 2017

0 Comments

Written by

Categories: Advocacy, Communications, Healthcare, Patient Communications

Expanded Access Programs Require Compassionate Communications to Keep Your Reputation Intact

No company wants to be seen as uncaring, least of all in the healthcare space. Clients I’ve supported in this sector are often passionate about their mission to bring new and better treatment options to patients. But companies’ intentions may...

February 20, 2017

0 Comments

Written by

Categories: Global Healthcare, Health and Wellness, Healthcare

Dr. Dave’s Med-Sci Matters

Genetically altering humans? Maybe we Khan! While advances in gene therapy research continue to accelerate, an enduring redline has been the germline – no tinkering with the DNA of a human embryo, egg or sperm. Doing so would mean not...

February 20, 2017

0 Comments

Written by

Categories: FDA News, Healthcare, The Week That Was

The Week That Was: Crises in Communications

Whether your cultural point of reference is Jay-Z or Annie!, we can all agree that last week was a “hard knock life” for orphans…orphan drugs, that is. We saw Marathon hit pause on its launch of Emflaza, the steroid approved...

February 7, 2017

0 Comments

Written by

Categories: Global Healthcare, Healthcare

Dr. Dave’s Med-Sci Matters

PCSK9 inhibitors (evolocumab and alirocumab) have been approved based primarily on studies showing they reduce LDL cholesterol (the “bad” cholesterol) and atherosclerotic plaque in patients with high LDLs and already taking statins. However, treaters and payors have been waiting for...